SLC5A2 and diabetes mellitus: In addition, it was shown that DPP-IV inhibitor together with SGLT2 inhibitor exerted more favorable effects on β-cell function and mass, especially in the early stage of diabetes mellitus compared to the advanced stage in type 2 diabetic db/db mice [90].